Introduction {#s1}
============

Photoreceptor cells transform information entering the eye as photons into patterns of neuronal electrical activity. This transformation takes place in the sensory cilium organelle, the outer segment. Outer segments are built from a relatively small set of structural and signaling proteins, including components of the classical G protein-coupled receptor (GPCR) phototransduction cascade. Such a distinct functional and morphological specialization allow outer segments to serve as a nearly unmatched model system for studying general principles of GPCR signaling ([@bib1]) and, in more recent years, a model for ciliary trafficking ([@bib11]; [@bib24]; [@bib26]; [@bib33]; [@bib37]).

Despite our deep understanding of visual signal transduction, little is known about how the outer segment is populated by proteins performing this function. Indeed, nearly all mechanistic studies of outer segment protein trafficking have been devoted to rhodopsin ([@bib24]; [@bib37]), which is a GPCR visual pigment comprising the majority of the outer segment membrane protein mass ([@bib25]). The mechanisms responsible for outer segment delivery of other transmembrane proteins remain essentially unknown. Some of them contain short outer segment targeting signals, which can be identified through site-specific mutagenesis ([@bib9]; [@bib21]; [@bib27]; [@bib32]; [@bib34]; [@bib35]; [@bib36]). A documented exception is retinal guanylate cyclase 1 (GC-1), whose exhaustive mutagenesis did not yield a distinct outer segment targeting motif ([@bib16]).

GC-1 is a critical component of the phototransduction machinery responsible for synthesizing the second messenger, cGMP ([@bib38]). GC-1 is the only guanylate cyclase isoform expressed in the outer segments of cones and the predominant isoform in rods ([@bib3]; [@bib39]). GC-1 knockout in mice is characterized by severe degeneration of cones and abnormal light-response recovery kinetics in rods ([@bib39]). Furthermore, a very large number of GC-1 mutations found in human patients causes one of the most severe forms of early onset retinal dystrophy, called Leber's congenital amaurosis ([@bib6]; [@bib18]). Many of these mutations are located outside the catalytic site of GC-1, which raises great interest in understanding the mechanisms of its intracellular processing and trafficking.

In this study, we demonstrate that, rather than relying on its own targeting motif, GC-1 is transported to the outer segment in a complex with rhodopsin. We conducted a comprehensive screen of outer segment protein localization in rod photoreceptors of rhodopsin knockout (*Rho^-/-^*) mice and found that GC-1 was the only protein severely affected by this knockout. Next, we showed that this unique property of GC-1 is explained by its interaction with rhodopsin, which likely initiates in the biosynthetic membranes and supports both intracellular stability and outer segment delivery of this enzyme. These findings explain how GC-1 reaches its specific intracellular destination and also expand the role of rhodopsin in supporting normal vision by showing that it guides trafficking of another key phototransduction protein.

Results {#s2}
=======

GC-1 is the outer segment-resident protein severely down-regulated in rhodopsin knockout rods {#s2-1}
---------------------------------------------------------------------------------------------

This study was initiated by testing the hypothesis that rhodopsin, by far the most abundant outer segment protein whose proper transport is essential for formation of this organelle, may affect trafficking and abundance of outer segment membrane proteins. This was accomplished by a comprehensive examination of outer segment protein localization in rods of *Rho^-/-^* mice. Normal outer segments are cylindrical structures filled with an ordered stack of several hundred membrane discs ([Figure 1A](#fig1){ref-type="fig"}). In contrast, *Rho^-/-^* rods only develop small ciliary extensions filled with disorganized membrane material ([Figure 1A](#fig1){ref-type="fig"}; [@bib14]; [@bib19]; [@bib20]). Despite this morphological defect, two outer segment-specific proteins, peripherin and R9AP, have been previously shown to reliably target to this ciliary extension ([@bib19]; [@bib27]). We broadened this analysis to include the majority of transmembrane outer segment proteins.10.7554/eLife.12058.003Figure 1.Localization of outer segment membrane proteins in wild-type (WT) and *Rho^-/-^* retinas.(**A**) Electron micrographs showing the outer segment and connecting cilium in WT and *Rho^-/-^* rods (scale bar 500 nm). (B--K) Immunofluorescent localization of individual outer segment proteins in WT and *Rho^-/-^* retinal cross-sections: (**B**) Rom-1; (**C**) ABCA4; (**D**) guanylate cyclase 2 (GC-2); (**E**) cyclic nucleotide gated (CNG) α1; (**F**) CNGβ1; (**G**) prominin; (**H**) protocadherin 21 (PCDH21); (**I**) peripherin; (**J**) R9AP; and (**K**) GC-1. (**L**) Double labeling of GC-1 (green) and the cone maker, PNA (magenta). Here and in the following figures, the identity of antibodies used in each panel is indicated in 'Materials and methods'. Scale bars, 10 μm. Nuclei are stained by Hoechst (blue).**DOI:** [http://dx.doi.org/10.7554/eLife.12058.003](10.7554/eLife.12058.003)

We analyzed ten proteins, whose antibodies have been verified in the corresponding knockout controls. Five of these proteins are components of the phototransduction cascade (R9AP, GC-1, GC-2, CNGα1, and CNGβ1), two support disc structure (peripherin and Rom1), one is a membrane lipid flippase (ATP-binding cassette transporter A4, ABCA4), and the last two are thought to participate in photoreceptor disc morphogenesis (protocadherin 21 and prominin). All experiments were performed with animals sacrificed on postnatal day 21 when the rudimentary outer segments of *Rho^-/-^* rods are fully formed, but photoreceptor degeneration that eventually occurs in these mice remains minimal.

Remarkably, nine out of ten proteins were localized specifically to the ciliary extensions of the *Rho^-/-^* rods. They included Rom1, ABCA4, GC-2, CNGα1, CNGβ1, protocadherin 21, and prominin ([Figure 1B--H](#fig1){ref-type="fig"}), as well as previously reported R9AP and peripherin ([Figure 1I,J](#fig1){ref-type="fig"}). A striking exception was GC-1, which displayed a punctate pattern in the outer segment layer with no distinct signal in rod ciliary extensions ([Figure 1K](#fig1){ref-type="fig"}). Further analysis using a cone marker, peanut agglutinin, revealed that the GC-1-positive puncta corresponds to cone outer segments ([Figure 1L](#fig1){ref-type="fig"}; note that cone outer segments in *Rho^-/-^* mice are smaller than normal). Faint fluorescent signal outside the cone outer segments was indistinguishable from non-specific background in the outer segment layer of GC-1 knockout mice (*Gucy2e^-/-^*; [Figure 2](#fig2){ref-type="fig"}). Interestingly, this effect was not reciprocal. As documented in a previous study ([@bib3]), the knockout of GC-1 was not associated with reduction or mislocalization of rhodopsin from rod outer segments ([Figure 2](#fig2){ref-type="fig"}).10.7554/eLife.12058.004Figure 2.Rhodopsin expression and outer segment localization do not rely on GC-1.Rhodopsin (magenta) and GC-1 (green) were co-immunostained in retinal cross-sections from wild-type (WT), *GC-1^-/-^*, and *Rho^-/-^* mice. Scale bar, 10 μm. Nuclei stained in blue.**DOI:** [http://dx.doi.org/10.7554/eLife.12058.004](10.7554/eLife.12058.004)

We then used quantitative Western blotting to measure the amounts of outer segment proteins in the retinas of *Rho^-/-^* knockout mice. Availability of suitable antibodies allowed us to analyze eight of the initial ten proteins ([Figure 3](#fig3){ref-type="fig"}). Serial dilutions of retinal lysates from wild-type (WT) and *Rho^-/-^* mice were run on the same blot (such as examples in [Figure 3A](#fig3){ref-type="fig"}) and the relative protein amounts were calculated using WT data to generate calibration curves. We found that proteins retaining their normal outer segment localization ([Figure 1](#fig1){ref-type="fig"}) were all expressed at 40--80% WT levels ([Figure 3B](#fig3){ref-type="fig"}). Considering how small the ciliary extensions of *Rho^-/-^* rods are, this amount of protein expression is quite remarkable and suggests a high density of protein packing.10.7554/eLife.12058.005Figure 3.Quantification of outer segment transmembrane proteins in *Rho^-/-^* retinas at P21. (**A**) Representative Western blots show serial dilutions of wild-type (WT) and *Rho^-/-^* retinal lysates for three proteins (guanylate cyclase 1 \[GC-1\], GC-2, and peripherin). The fluorescent signal produced by each band in the serial dilution was plotted and used to calculate the amount of each protein in *Rho^-/-^* lysate. In these examples, GC-1 was to 10% of its WT content, GC-2 to 38%, and peripherin to 57%. (**B**) Expression levels of outer segment transmembrane proteins in *Rho^-/-^* retinal lysates calculated as %WT. A minimum of four independent experiments was performed for each protein. Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12058.005](10.7554/eLife.12058.005)10.7554/eLife.12058.006Figure 3---figure supplement 1.Transcript levels of GC-1 in the retinas of WT and *Rho^-/-^* mice.Quantitative RT-PCR of each transcript was performed on four mice of each genotype at P21. The relative mRNA expression level in each sample was normalized to the inner retina marker, Thy1. Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12058.006](10.7554/eLife.12058.006)

Once again the outlier was GC-1 whose content in *Rho^-/-^* retinas was only 10 ± 3% (SEM, n=5) of WT ([Figure 3A,B](#fig3){ref-type="fig"}). Considering that (1) a large fraction of this GC-1 is expressed in cones ([Figure 1L](#fig1){ref-type="fig"}); (2) cones comprise 3% of mouse photoreceptors; and (3) cones express more GC-1 than rods ([@bib10]), our most conservative estimate is that GC-1 in *Rho^-/-^* rods is reduced by at least 95%. This reduction is not caused by a loss of the GC-1 transcript, since qRT-PCR showed that the amount of GC-1 mRNA in *Rho^-/-^* retinas was actually twice higher than in WT retinas ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), perhaps reflecting a feedback mechanism attempting to compensate for the missing GC-1 enzyme.

Taken together, the data reported in [Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"} demonstrate that GC-1 is unique among outer segment transmembrane proteins in its reliance on rhodopsin for intracellular stability and outer segment localization. We next addressed the mechanistic basis for this phenomenon.

GC-1 stability and trafficking require the transmembrane core of rhodopsin but not its outer segment targeting domain {#s2-2}
---------------------------------------------------------------------------------------------------------------------

We first asked whether the stability and localization of GC-1 in rods require rhodopsin itself or the activity of rhodopsin's trafficking pathway. The outer segment localization of rhodopsin relies on its C-terminal sequence (including the VXPX targeting motif), which is both necessary and sufficient for rhodopsin delivery ([@bib9]; [@bib21]; [@bib34]; [@bib35]). Taking advantage of the fact that adding this sequence to other proteins enables their specific outer segment trafficking ([@bib35]; reviewed in [@bib26]), we used chimeric proteins to address this question. Two chimeras were generated by exchanging the seven-helical cores and C-terminal sequences between rhodopsin and another GPCR, serotonin receptor Htr6, whose topology is close to rhodopsin. Although this receptor is not endogenous to rods, we found that both full-length Htr6 and its rhodopsin chimeras robustly express and reliably target to rod outer segments of WT and *Rho^-/-^* mice. This is shown in [Figure 4](#fig4){ref-type="fig"}, where these constructs were introduced into rods by the technique of *in vivo* electroporation.10.7554/eLife.12058.007Figure 4.Guanylate cyclase 1 (GC-1) rescue in Rho-/- rods requires the seven-helical core structure of rhodopsin.Wild-type (WT) and *Rho^-/-^* rods were transfected with (**A**) full-length Htr6, (**B**) seven-helical Htr6 core fused to rhodopsin's C-terminus, (**C**) seven-helical rhodopsin core fused to the C-terminus of Htr6, (**D**) full-length rhodopsin. Sections from WT retinas were stained for each recombinant chimera using anti-green fluorescent protein (GFP), anti-myc, or anti-FLAG antibodies (magenta, each chimera's tag is depicted in the construct diagram). Sections from *Rho^-/-^* retinas were co-stained for GFP, myc, or FLAG (magenta, left panel) and endogenous GC-1 using anti-GC1 antibodies (green, middle panel). The merged images from *Rho^-/-^* sections are shown in the right panel. Scale bar, 10 μm. Nuclei are stained by Hoechst (blue).**DOI:** [http://dx.doi.org/10.7554/eLife.12058.007](10.7554/eLife.12058.007)

Despite its strong expression in outer segments of *Rho^-/-^* rods, Htr6 did not restore their GC-1 content ([Figure 4A](#fig4){ref-type="fig"}) and neither did the chimera containing the Htr6 seven-helical core fused to rhodopsin's C-terminus ([Figure 4B](#fig4){ref-type="fig"}). In contrast, expression of the chimera containing rhodopsin's core fused to Htr6's C-terminus did restore GC-1 in the outer segments of transfected rods ([Figure 4C](#fig4){ref-type="fig"}), as efficiently as rhodopsin ([Figure 4D](#fig4){ref-type="fig"}). Therefore, both intracellular stability and outer segment delivery of GC-1 rely directly on rhodopsin and not on the activity of the ciliary trafficking pathway driven by rhodopsin's C-terminus. The most straightforward explanation of this finding is that stability and trafficking of GC-1 are being supported by its binding to rhodopsin -- a hypothesis tested in the next set of experiments.

GC-1 is a rhodopsin-interacting protein {#s2-3}
---------------------------------------

We investigated whether GC-1 and rhodopsin interact with one another by co-precipitating them from mouse retinal membranes solubilized in a mild detergent, dodecyl maltoside. The experiment in [Figure 5A](#fig5){ref-type="fig"} demonstrates that a large fraction of GC-1 can be co-precipitated with rhodopsin using the monoclonal anti-rhodopsin antibody 1D4. The specificity of this co-precipitation was established by replacing 1D4 with non-immune mouse IgG and by performing the experiment in the presence of the 1D4 epitope-blocking peptide ([@bib13]). Neither rhodopsin nor GC-1 was precipitated under these conditions. We also probed the 1D4 precipitate for the chaperone protein, DnaJB6 ([Figure 5A](#fig5){ref-type="fig"}), which was previously shown to link GC-1 to the intraflagellar transport (IFT) particle for ciliary transport ([@bib5]). Whereas a strong DnaJB6 staining was identified in the retinal lysate, it did not precipitate with the rhodopsin-GC-1 complex. This suggests that, unlike the interaction with rhodopsin, the GC-1 interaction with DnaJB6 is transient. Following a recent report that another rhodopsin-binding protein is peripherin ([@bib4]), we also probed the rhodopsin precipitate for peripherin. However, no appreciable fraction of peripherin was found in precipitate, both under our experimental conditions and in membranes dissolved in Triton X-100 as in their study. Given that these authors did not show what fraction of total peripherin was precipitating with rhodopsin in their assays, it is hard to fully reconcile these observations, although it is highly unlikely that rhodopsin's interaction with peripherin could be as prominent as that with GC-1.10.7554/eLife.12058.008Figure 5.Guanylate cyclase 1 (GC-1) co-precipitation with rhodopsin from mouse retinal lysate. (**A**) GC-1 and rhodopsin co-precipitation by monoclonal anti-rhodopsin antibody 1D4. Wild-type (WT) mouse retinal lysate (Input) was incubated with 1D4 antibody and then bound to protein A/G beads. After the unbound material in flow through (FT) was removed, the beads were washed and bound proteins were eluted (Eluate) and analyzed by Western blotting for GC-1, rhodopsin, DnaJB6, and peripherin. Non-specific protein binding was probed using either non-immune mouse IgG or 1D4 antibody treated with its epitope blocking peptide. (**B**) Co-precipitation of GC-1 and rhodopsin by the 1D4 antibody from retinal membranes solubilized under different detergent conditions. (**C**) Rhodopsin and GC-1 co-precipitation by monoclonal anti-GC-1 antibody 1S4. *Rho^+/-^* mouse retinal lysate (Input) was incubated with 1S4 antibody bound to protein A/G beads. After the unbound material in flow through (FT) was removed, bound proteins were eluted from the beads (Eluate) and analyzed by Western blotting for GC-1 and rhodopsin. Non-specific rhodopsin binding was probed using non-immune mouse IgG. Protein loading on each lane was normalized to input in all panels.**DOI:** [http://dx.doi.org/10.7554/eLife.12058.008](10.7554/eLife.12058.008)

Importantly, the efficiency of GC-1 co-precipitation with rhodopsin was highly dependent on the type and concentration of detergent used for membrane solubilization. The co-precipitated fraction of GC-1 diminished when we increased the concentration of dodecyl maltoside, or used Triton X-100 instead ([Figure 5B](#fig5){ref-type="fig"}). Such instability of membrane protein complexes in detergent solutions is a common phenomenon ([@bib31]), and we believe that this likely hindered identification of GC-1's interaction with rhodopsin in the past.

The reciprocal co-precipitation of rhodopsin by the monoclonal anti-GC-1 antibody 1S4 is shown in [Figure 5C](#fig5){ref-type="fig"}. The challenge of this experiment was that rhodopsin in mouse rods is expressed at a 1400-fold molar excess over GC-1 ([@bib29]). Therefore, the theoretical limit of rhodopsin bound to GC-1 is only 0.07% of its total amount, and its detection requires special measures to reduce non-specific rhodopsin binding to the beads. We addressed this issue by employing two strategies. First, we improved the molar ratio between GC-1 and rhodopsin by using retinal lysates from *Rho^+/-^* mice, which express twice less rhodopsin without affecting the amounts of other outer segment proteins ([@bib7]; [@bib22]). Second, we used a minimal amount of beads fully saturated with anti-GC-1 antibodies, just sufficient to precipitate the majority of GC-1 in the lysate. Under these conditions, rhodopsin precipitation with anti-GC-1 antibody exceeded non-specific background with non-immune IgG by over six-fold (6.5 ± 1.7, n=3).

Taken together and combined with our finding that the intracellular stability of GC-1 is critically dependent on the presence of rhodopsin, these data demonstrate that rhodopsin and GC-1 form a complex in photoreceptor cells.

Discussion {#s3}
==========

The findings reported in this study expand our understanding of how the photoreceptor's sensory cilium is populated by its specific membrane proteins. We have found that rhodopsin serves as an interacting partner and a vehicle for ciliary delivery of a key phototransduction protein, GC-1. This previously unknown function adds to the well-established roles of rhodopsin as a GPCR visual pigment and a major building block of photoreceptor membranes. We further showed that GC-1 is unique in its reliance on rhodopsin, as the other nine proteins tested in this study were expressed in significant amounts and faithfully localized to rod outer segments in the absence of rhodopsin.

Our data consolidate a number of previously published observations, including a major puzzle related to GC-1: the lack of a distinct ciliary targeting motif encoded in its sequence. The shortest recombinant fragment of GC-1 which localized specifically to the outer segment was found to be very large and contain both transmembrane and cytoplasmic domains ([@bib16]). Our study shows that GC-1 delivery requires rhodopsin and, therefore, can rely on specific targeting information encoded in the rhodopsin molecule. Interestingly, we also found that this information can be replaced by an alternative ciliary targeting sequence from a GPCR not endogenous to photoreceptors. This suggests that the functions of binding/stabilization of GC-1 and ciliary targeting are performed by different parts of the rhodopsin molecule.

Our findings also shed new light on the report that both rhodopsin and GC-1 utilize IFT for their ciliary trafficking and co-precipitate with IFT proteins ([@bib5]). The authors hypothesized that GC-1 plays a primary role in assembling cargo for the IFT particle bound for ciliary delivery. Our data suggest that it is rhodopsin that drives this complex, at least in photoreceptor cells where these proteins are specifically expressed. Unlike GC-1's reliance on rhodopsin for its intracellular stability or outer segment trafficking, rhodopsin does not require GC-1 as its expression level and localization remain normal in rods of GC-1 knockout mice ([@bib3]; and this study). The outer segment trafficking of cone opsins is not affected by the lack of GC-1 either ([@bib3]; [@bib15]), although GC-1 knockout cones undergo rapid degeneration, likely because they do not express GC-2 -- an enzyme with redundant function. The primary role of rhodopsin in guiding GC-1 to the outer segment is further consistent with rhodopsin directly interacting with IFT20, a mobile component of the IFT complex responsible for recruiting IFT cargo at the Golgi network ([@bib8]; [@bib17]).

It was also reported that GC-1 trafficking requires participation of chaperone proteins, most importantly DnaJB6 ([@bib5]). Our data suggest that GC-1 interaction with DnaJB6 is transient, most likely in route to the outer segment, since we were not able to co-precipitate DnaJB6 with GC-1 from whole retina lysates ([Figure 5](#fig5){ref-type="fig"}). In contrast, the majority of GC-1 co-precipitates with rhodopsin from these same lysates, suggesting that these proteins remain in a complex after being delivered to the outer segment. Although our data do not exclude that the mature GC-1-rhodopsin complex may contain additional protein component(s), our attempts to identify such components by mass spectrometry have not yielded potential candidates.

Interestingly, GC-1 was previously shown to stably express in cell culture where it localizes to either ciliary or intracellular membranes ([@bib5]; [@bib30]). This strikes at the difference between the composition of cellular components supporting membrane protein stabilization and transport in cell culture models versus functional photoreceptors. The goal of future experiments is to determine whether these protein localization patterns would be affected by co-expressing GC-1 with rhodopsin, thereby gaining further insight into the underlying intracellular trafficking mechanisms.

Finally, GC-1 trafficking was reported to depend on the small protein RD3, which is thought to stabilize both guanylate cyclase isoforms, GC-1 and GC-2, in biosynthetic membranes ([@bib2]; [@bib40]). In the case of GC-1, this stabilization would be complementary to that by rhodopsin and potentially could take place at different stages of GC-1 maturation and trafficking in photoreceptors. Another proposed function of RD3 is to inhibit the activity of guanylate cyclase isoforms outside the outer segment in order to prevent undesirable cGMP synthesis in other cellular compartments ([@bib28]).

In summary, this study explains how GC-1 reaches its intracellular destination without containing a dedicated targeting motif, expands our understanding of the role of rhodopsin in photoreceptor biology and extends the diversity of signaling proteins found in GPCR complexes to a member of the guanylate cyclase family. Provided that the cilium is a critical site of GPCR signaling in numerous cell types ([@bib33]), it would be interesting to learn whether other ciliary GPCRs share rhodopsin's ability to stabilize and deliver fellow members of their signaling pathways.

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

WT C57BL/6J mice were from Jackson Labs (Bar Harbor, ME), WT CD-1 mice were from Charles River, *Rho ^-/-^* mice ([@bib20]) were kindly provided by Janis Lem (Tufts University), and fixed eyecups from *Gucy2e^-/-^* mice ([@bib39]) were kindly provided by Shannon Boye (University of Florida).

Primary antibodies {#s4-2}
------------------

The following antibodies (with corresponding figures indicated) were generously provided by: David Garbers, University of Texas Southwestern (pAb L670, anti-GC2; [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}); Alexander Dizhoor, Salus University (pAb KHD, anti-RetGC1; [Figures 3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}); Wolfgang Baehr, University of Utah (mAb 1S4, anti-RetGC1; [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}); Robert Molday, University of British Columbia (mAb 1D1 PMC, anti-CNGα1; [Figure 1](#fig1){ref-type="fig"}); Steven Pittler, University of Alabama at Birmingham (pAb, anti-CNGβ1; [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}); Gabriel Travis, University of California Los Angeles (pAb, anti-peripherin residues 296--346; [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}); Jeremy Nathans, Johns Hopkins University (pAb, anti-protocadherin 21 C-terminus; [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}); Stefan Heller, Stanford University (pAb, anti-R9AP residues 144--223; [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}).

The polyclonal antibody against Rom-1 was generated in our laboratory ([@bib12]) ([Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}). Commercial antibodies were: mAb 1D4, anti-rhodopsin (Abcam, Cambridge, MA, [Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}); pAb, anti-rhodopsin N-terminus (Sigma, St. Louis, MO; [Figure 2](#fig2){ref-type="fig"}); pAb M-18, anti-ABCA4 (Santa Cruz, Dallas, TX; [Figure 3](#fig3){ref-type="fig"}); pAb, anti-ABCA4 C-terminus (Everest Biotech, Ramona, CA; [Figure 1](#fig1){ref-type="fig"}); mAb 13A4, anti-prominin (eBioscience, San Diego, CA; [Figure 1](#fig1){ref-type="fig"}); mAb M2, anti-FLAG (Sigma; [Figure 4](#fig4){ref-type="fig"}) and pAb, anti-FLAG (Pierce, Grand Island, NY; [Figure 4](#fig4){ref-type="fig"}); pAb, anti-GFP conjugated to Alex Fluor 488 (Molecular Probes, Grand Island, NY; [Figure 4](#fig4){ref-type="fig"}); pAb 71D10, anti-Myc-Tag (Cell Signaling, Danvers, MA; [Figure 4](#fig4){ref-type="fig"}); pAb, anti-DnaJB6 (Thermo Scientific, Grand Island, NY; [Figure 5](#fig5){ref-type="fig"}).

Immunofluorescence {#s4-3}
------------------

Posterior eyecups from C57BL/6J, *Rho ^-/-^*, or *GC1^-/-^* mice were fixed for 1 hr with 4% paraformaldehyde in mouse Ringer's solution, rinsed three times in Ringer's, and embedded in 4% UltraPure agarose (Invitrogen, Grand Island, NY). Cross-sections of 100 μm were collected using a vibratome (Leica Biosystems, Buffalo Grove, IL), placed in 24-well plates, and blocked in 5% goat serum and 0.5% Triton X-100 in PBS for 1 hr at 22**°**C. Sections were incubated with primary antibodies in blocking solution overnight at 4**°**C, rinsed three times, and incubated with goat secondary antibodies conjugated with Alexa Fluor 488, 568, or 647 (Invitrogen) in blocking solution for 2 hr at 22**°**C. To stain nuclei, 5 μg/ml Hoechst - (33342, Invitrogen) was used. To stain mouse cones, 1 μg/ml lectin peptide nucleic acid (PNA) conjugated to Alexa Fluor 488 (Molecular Probes) was used. Sections were mounted with Immu-Mount (Thermo Scientific) and cover-slipped. Images were acquired using a Nikon Eclipse 90i microscope and a C1 confocal scanner controlled by EZ-C1, version 3.10 software.

Western blotting {#s4-4}
----------------

Retinas from C57BL/6J or *Rho ^-/-^* mice were collected at P21 and sonicated in 250 μl of 2% sodium dodecyl sulfate and 1× cOmplete protease inhibitor mixture (Roche, Indianapolis, IN) in phosphate-buffered saline (PBS). Lysates were cleared at 5,000 g for 10 min at 22**°**C. Total protein concentration was measured using the RC DC Protein Assay kit (Bio-Rad, Hercules, CA) and serial dilutions of each lysate were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (with samples not boiled). For most proteins, Western blotting was performed using secondary goat or donkey antibodies conjugated with Alexa Fluor 680 or 800 (Invitrogen) and bands were visualized and quantified using the Odyssey infrared imaging system (LiCor Bioscience). Bands of PCDH21 and CNGβ1 were visualized using goat or donkey secondary antibodies conjugated with horseradish peroxidase (HRP) for enhanced chemiluminescence (ECL) detection (ECL Prime, GE Healthcare, Pittsburgh, PA).

In vivo electroporation and DNA constructs {#s4-5}
------------------------------------------

DNA constructs were electroporated into the retinas of WT CD-1 or *Rho^-/-^* neonatal mice ([@bib23]), using a detailed protocol from [@bib12]. The pRho plasmid driving gene expression under the 2.2 kb bovine rhodopsin promoter was a gift from Connie Cepko (Addgene, Cambridge, MA; plasmid \# 11156). All DNA constructs were cloned between the 5' AgeI and 3' NotI sites in pRho. Full-length mouse rhodopsin and peripherin were cloned from mouse retinal cDNA. A single N-terminal FLAG tag was added to the 5' end of rhodopsin using overlap extension PCR. The 5-Htr6 serotonin receptor was amplified from a mouse brain cDNA library (Stratagene, La Jolla, CA) and the coding sequence for eGFP was fused to its 3' end. All chimeric constructs were produced using overlap extension PCR. Rhodopsin was split at amino acid 323, 5-Htr6 was split at amino acid 322, and the C-terminal 63 amino acids from peripherin were used in the chimera with truncated rhodopsin. Each DNA plasmid (4 μg/μl) was mixed with a construct expressing soluble mCherry (2 μg/μl) for fluorescent identification of electroporated retinal patches. At least four animals yielding consistent results were analyzed for each construct.

Protein co-immunoprecipitation {#s4-6}
------------------------------

One C57BL/6J or *Rho^+/-^* retina was homogenized in 200 μl of PBS with 1× phosphatase inhibitor cocktail (PhosSTOP, Roche), 1× cOmplete protease inhibitor mixture (Roche), and either n-dodecyl β-D-maltoside or Triton X-100 at desired concentration. Gentle homogenization was performed using a pestle on ice without vortexing or sonication. Lysates were cleared at 100,000 g for 20 min at 4°C and 20 μl aliquots were incubated with primary antibodies overnight at 4°C under continuous rotation (5 μg of anti-rhodopsin antibody 1D4, 0.2 μg of anti-GC-1 antibody 1S4, or mouse monoclonal IgG, Santa Cruz). For epitope blocking, rhodopsin 1D4 peptide (AnaSpec, Fremont, CA) was added to lysate with 1D4 antibody at a final concentration of 2 mM. Protein A/G magnetic beads (Pierce) were incubated with the lysate under rotation for 15 min at 22°C; 25 μl of beads were used to precipitate antibodies bound to rhodopsin, while 5 μl of beads were used to precipitate GC-1. Flow through was collected and beads were washed in 100 μl of the corresponding lysate buffer before being eluted with 20 μl of 2% sodium dodecyl sulfate (SDS) in PBS. Finally, 5 μl of 6× sample buffer with 100 mM dithiothreitol (DTT) were added to each sample (input, flow through, eluate) for SDS-PAGE. Samples were not boiled.

Quantitative RT-PCR {#s4-7}
-------------------

Retinas were collected from C57BL/6J or *Rho^-/-^* mice at P21, and RNA was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA) and adjusted to 50 ng/μl. cDNA was then synthesized from total RNA using the QuaniTect Reverse Transcriptase kit (Qiagen). GC-1 and Thy1 (internal control) primers were designed to PCR across exons 2 and 3 (GC-1 Fwd ATCCGAGATGGGCCTAGAGT, GC-1 Rev AGCCAGTTCTTCTGCAGCTT, Thy1 Fwd GTCGCTCTCCTGCTCTCAGT, and Thy1 Rev GTTATTCTCATGGCGGCAGT). The concentrations of GC-1 and Thy1 in each sample were determined using a standard curve generated by serial dilutions of the corresponding gel-purified PCR products. Real time PCR was performed in a 10 μl reaction volume with 0.5 μl of cDNA using the iQ SYBR Green Supermix (Biorad). Thermal cycling and SYBR detection was performed on a CFX96 Real Time System (Biorad).
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Thank you for submitting your work entitled \"Guanylate cyclase 1 relies on rhodopsin for intracellular stability and ciliary trafficking\" for consideration by *eLife*. Your article has been reviewed by two expert peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gary Westbrook as the Senior Editor. The experts\' comments together with the Reviewing Editor\'s assessment form the basis of this letter, and their reviews are included at the end. The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Nikolai Artemyev (Reviewer \#1) and Theodore Wensel (Reviewer \#2).

The reviewers and the editor were impressed with the importance and novelty of your work. The only suggestion, and it is just that -- a suggestion -- is to consider looking at GC1 and rhodopsin co-localization in transfected cells. We look forward to receiving the revised version of your manuscript.

Reviewer \#1:

The study by Pearring et al. is interesting and well executed. The authors investigated which of the outer segment membrane resident proteins depend on rhodopsin for proper localization using Rho KO mice. Out of the ten examined proteins, only GC1 failed to traffic to the OS in the absence rhodopsin and was severely downregulated. Moreover, GC1 was found to directly interact with rhodopsin, thus suggesting the mechanism for rhodopsin in the transport of GC1. The conclusion is that GC1 is delivered to the OS in the complex with rhodopsin seems as the most probable, but not exclusive, interpretation of the findings. Hypothetically, rhodopsin may stabilize or chaperone GC1, but then mature GC1 can traffic to the OS independent of rhodopsin. Co-immunoprecipitation of GC1 and rhodopsin does not rule out the latter possibility if the binding is induced by mild destabilization of GC1 by detergent. A few additional experiments could bolster the authors\' conclusions. In transfected HEK293 cells, rhodopsin localizes to the plasma membrane even in the absence of the C-terminal targeting signal, whereas GC1 is restricted to the ER. The authors can test if co-transfection with rhodopsin will target GC1 to the plasma membrane. Also, it would be helpful to confirm the binding of rhodopsin to GC1 in the OS by means other than IP (proximity ligation assay, FRET, etc.)

Reviewer \#2:

This is an interesting and well-executed study revealing that binding to rhodopsin is essential for guanylate cyclase isoform GC-1 trafficking to rod outer segments. Although this appears to be a one-of-a-kind interaction in rods, it has potential implications for disease mechanisms, and there may be analogous mechanisms in other ciliated cells. The quality of the data is excellent, with quantitative comparisons being carried out by MS and by carefully calibrated immunoblotting. The comparison of IP efficiencies in different detergents is an important procedure that should be used more often for membrane protein complexes.
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*The reviewers and the editor were impressed with the importance and novelty of your work. The only suggestion, and it is just that -- a suggestion -- is to consider looking at GC1 and rhodopsin co-localization in transfected cells. We look forward to receiving the revised version of your manuscript.*Reviewer \#1:

The study by Pearring et al. is interesting and well executed. The authors investigated which of the outer segment membrane resident proteins depend on rhodopsin for proper localization using Rho KO mice. Out of the ten examined proteins, only GC1 failed to traffic to the OS in the absence rhodopsin and was severely downregulated. Moreover, GC1 was found to directly interact with rhodopsin, thus suggesting the mechanism for rhodopsin in the transport of GC1. The conclusion is that GC1 is delivered to the OS in the complex with rhodopsin seems as the most probable, but not exclusive, interpretation of the findings. Hypothetically, rhodopsin may stabilize or chaperone GC1, but then mature GC1 can traffic to the OS independent of rhodopsin. Co-immunoprecipitation of GC1 and rhodopsin does not rule out the latter possibility if the binding is induced by mild destabilization of GC1 by detergent. A few additional experiments could bolster the authors\' conclusions. In transfected HEK293 cells, rhodopsin localizes to the plasma membrane even in the absence of the C-terminal targeting signal, whereas GC1 is restricted to the ER. The authors can test if co-transfection with rhodopsin will target GC1 to the plasma membrane. Also, it would be helpful to confirm the binding of rhodopsin to GC1 in the OS by means other than IP (proximity ligation assay, FRET, etc.)

Reviewer \#2:

This is an interesting and well-executed study revealing that binding to rhodopsin is essential for guanylate cyclase isoform GC-1 trafficking to rod outer segments. Although this appears to be a one-of-a-kind interaction in rods, it has potential implications for disease mechanisms, and there may be analogous mechanisms in other ciliated cells. The quality of the data is excellent, with quantitative comparisons being carried out by MS and by carefully calibrated immunoblotting. The comparison of IP efficiencies in different detergents is an important procedure that should be used more often for membrane protein complexes.

We appreciate the suggestion to co-express GC1 and rhodopsin in cell culture, however our laboratory is not currently conducting any cell culture studies and, starting from scratch, we are unlikely to be able to complete this task within the amount of time reasonable for a revision. It might be a better idea to address it in a separate investigation, in collaboration with one of the laboratories currently conducting this cell culture work and also performing functional assays of expressed GC1. Or, perhaps, our study will inspire them to pursue such a follow-up study, whereas our focus would remain on elucidating ciliary trafficking pathways in photoreceptors. We hope the reviewer understands; we certainly do not mean to just dismiss this thoughtful comment.

Regarding the second point of Reviewer \#1, we cannot completely dismiss the hypothetic possibility that rhodopsin may stabilize or chaperone GC1, but then mature GC1 can traffic to the OS independent of rhodopsin. We think, however, that our detergent result argues that rhodopsin-GC1 complex is de-stabilized rather than stabilized by detergent, as the complex was readily breaking apart when the concentration of a very mild detergent, dodecyl maltoside, was increased from a low value (0.1%) to the levels at which this detergent is used in the majority of published studies. We addressed this concern by replacing "indicating" with "suggesting" in the paragraph outlining this logic. Regarding FRET or proximity ligation assay, we thought about these options, but unfortunately they do not apply to the conditions of outer segment membranes containing 6 mM rhodopsin. This concentration is so high that rhodopsin is always within the FRET or PLA distance to other proteins populating these membranes, regardless of whether they are in a proper complex.
